Providing more affordable full-length single-cell mRNA sequencing with industry-leading coverage and sensitivity for in-depth cellular characterization SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA sequencing application for the C1™ system that provides deep coverage and high sensitivity while reducing sample preparation costs […]
PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partnersproviding products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of 2018, will […]
Industry Veteran Previous Served as EVP & Chief Commercial Officer of Illumina MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that it has appointed industry veteran Christian Henry to its Board of Directors. Mr. Henry has over 20 years of leadership experience, including over […]
Proceeds to fund further development of breakthrough DNA sequencing platform SAN DIEGO — Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing. The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and […]
BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune System FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq assay to analyze protein expression at the single-cell level using high-throughput sequencing. The assay brings together high-quality antibodies from […]
BEVERLY, Mass. — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, today announced that it has entered into the beta stage of product development of its flagship pathogen detection system. The Company recently completed a $5.7M equity financing through a bought deal short-form prospectus offering that included a fully-subscribed […]
Making genomics and artificial intelligence (AI) technologies work together can spot the origin of a genetic mutation causing cancer or a particular condition so that the treatment can be provided on time. Predicting treatment responses in cancer patients by integrating genomics and artificial intelligence is going to become a reality. A major collaborative research project “Artificial Intelligence […]
IRVINE, Calif. — Zymo Research Corp. has announced the appointment of Joseph R. Ecker, Ph.D., to Zymo Research’s Scientific Advisory Board. Dr. Ecker serves as Professor of Plant Molecular and Cellular Biology Laboratory and Director of the Genomic Analysis Laboratory at the Salk Institute for Biological Studies located in La Jolla, CA. He is also an Investigator for the Howard […]
Mick Messman Brings Over 20 Years of Global Agricultural Sales, Marketing, Product Development and Operations Experience to GreenLight MEDFORD, Mass. — GreenLight Biosciences, Inc., a biotechnology company developing RNA-based products for agricultural and pharmaceutical applications, today announced that Mick Messman has joined the Company as Chief Commercial Officer. Mr. Messman has over 20 years of global agricultural sales, […]
Streamlines genome interpretation to improve the utility of genomic data Illumina, Inc. announces the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals. The new AI software for genome interpretation has been publicly released through Illumina’s BaseSpace Sequence Hub and GitHub. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
